ArticleDer Urologe. Ausg. A2017

[Cost effectiveness of GnRH antagonists in patients with prostate cancer and cardiovascular risk : Comparative analysis against Leuprorelin by the Number Needed to Treat].

D Anderson et al.PubMed ↗Publisher ↗

No numbers read from the abstract.